PHL 211 Pharmacology Second Lecture By Abdelkader Ashour, Ph.D. Phone: 4677212

Slides:



Advertisements
Similar presentations
Cell Communication Cells need to communicate with one another, whether they are located close to each other or far apart. Extracellular signaling molecules.
Advertisements

Types of Cellular Secretion of Hormones Blood Transport of Hormones General Mechanisms of Hormonal Actions Asha Alex Physiology.
CHAPTER 10 Basic Biopharmaceutics
Pharmacology-1 PHL 313 Fifth Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology-1 PHL 313 Second Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology-1 PHL 313 Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology PHL 211 Ninth Lecture By Abdelkader Ashour, Ph.D. Phone:
PHL 211 Pharmacology Fifth Lecture By Abdelkader Ashour, Ph.D. Phone:
PHL 210 Pharmacology First Lecture By Abdelkader Ashour, Ph.D. Phone:
PHL 211 Pharmacology Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology-1 PHL 313 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
Receptors Lesson 8. Ligands & Receptors n Ligand l neurotransmitters l drugs n Receptor proteins l ligand binds to multiple receptors l receptor subtypes.
MEDICINES Done by Vishal Rajesh Lakhiani 12 - O. INTRODUCTION  Drug – A chemical of low molecular mass (100 – 500u) which interact with macromolecular.
Principles of Pharmacology: Pharmacodynamics
Principles of Pharmacology: Pharmacodynamics
Dr. Steven I. Dworkin Pharmacology for the Health Sciences Lecture 2a.
Section 1, Lecture 7 Pharmacodynamics
PHC 222 Part(I) Dr. Huda Al Salem Lecture (7). Factors that affect the efficacy 2- Concentration-Response Curves: Agonist Antagonist Partial agonist Desensetization.
Abdelkader Ashour, Ph.D. 1st & 2nd Lectures
 Receptors are mostly membrane-bound proteins that selectively bind small molecules called ligands which results in physiological response.  They are.
Cellular Internet Cell to cell communication is essential in order for organisms to coordinate activities that develop, survive and reproduce Cell communication.
Membranes & Receptors Chemical compounds & electricity are the medium through which, cells communicate! Analogous with information sent via electrical.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
Synaptic Transmission How a neuron communicates with another neuron and the effects of drugs on this process. Types of Neurotransmitters.
Biology Chapter 8 Section 3. Key Ideas  How do cells use signal molecules?  How do cells receive signals?  How do cells respond to signaling?
How drugs Act :General principles Lecture 2
Year One Pharmacodynamics
The Membrane Plays a Key Role in a Cell’s Response to Environmental Signals Cells can respond to many signals if they have a specific receptor.
Chemical messengers. intro Chemical messengers include neurotransmitters (very short distance), paracrine agents (short distance) and hormones (long distance)
Chapter 11 Cell Communication. Single Transduction Pathway The process in which a signal on a cells surface is converted into a specific cellular response.
ENZYMES and METABOLIC REACTIONS.  How do reactions occur in cells ?  Molecules are in constant motion  Collisions between molecules allow reactions.
Intracellular Signal Transduction Pathways and Cascades.
Chemical messengers. intro Chemical messengers include neurotransmitters (short distance) and hormones (long distance) Whatever the messenger, the cell.
How Do Drugs Affect Synapses? BY RUI XIAO. Psychoactive Drugs  Psychoactive drugs are chemical substances that can alter brain functions and result in.
DRUG RECEPTORS AND PHARMACODYNAMICS
Pharmacodynamics. * The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced * The.
January 26, 2016 Journal: What is the function of hormones?
How do you think cells communicate?
Pharmacology-1 PHL 351 Abdelkader Ashour, Ph.D..
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Enzymes Regulatory enzymes are usually the enzymes that are the rate-limiting, or committed step, in a pathway, meaning that after this step a particular.
PHL 210 Pharmacology Second Lecture By Abdelkader Ashour, Ph.D. Phone:
Understanding the Basics of Pharmacology
Drug-Receptor Binding and Receptor Types
IB Psych 10/10/17 Today’s Agenda:
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Cell Signaling (Lecture 1)
Cell Signaling.
Chapter 11 Cell Communication.
Cell Communication.
Cell Communication.
Drug-Receptor Interactions
INTRODUCTION to Pharmacology
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Cell Communication.
Receptors & Drug action at Receptors
Drug-Receptor Interactions
Chapter 18a The Endocrine System
Pharmacology UG-Course
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Cell Communication.
Cell Communication.
Pharmacodynamic Dr. Hashem Mansour.
Introduction to Pharmacology
Pharmacodynamics i Prof. hanan Hagar.
Introduction to Pharmacology
Drug-Receptor Interactions
Pharmacodynamics BSCI 493 March 2008.
Presentation transcript:

PHL 211 Pharmacology Second Lecture By Abdelkader Ashour, Ph.D. Phone:

 Receptor/Binding site “A specific protein in either the plasma membrane or interior of a target cell with which a ligand/drug combines”  It must be selective in choosing ligands to bind  To avoid constant activation of the receptor by promiscuous binding of many different ligands  It must change its function upon binding in such a way that the function of the biologic system (cell, tissue, etc) is altered  This is necessary for the ligand to cause a pharmacologic effect Drug Receptors

 Receptor/Binding site “A specific protein in either the plasma membrane or interior of a target cell with which a ligand/drug combines”  It must be selective in choosing ligands/drugs to bind  To avoid constant activation of the receptor by promiscuous binding of many different ligands  It must change its function upon binding in such a way that the function of the biologic system (cell, tissue, etc) is altered  This is necessary for the ligand to cause a pharmacologic effect

Drug Receptors  Receptor/Binding site “A specific protein in either the plasma membrane or interior of a target cell with which a ligand/drug combines”  It must be selective in choosing ligands/drugs to bind  To avoid constant activation of the receptor by promiscuous binding of many different ligands  It must change its function upon binding in such a way that the function of the biologic system (cell, tissue, etc) is altered  This is necessary for the ligand to cause a pharmacologic effect Drug  Orphan receptors “Receptors for which no ligand has been discovered but they have a similar structure to other identified receptors and whose function can only be presumed”  If a ligand for an orphan receptor is later discovered, the receptor is referred to as "adopted orphan receptor"  In order to interact chemically with its receptor, a drug molecule must have the appropriate size, electrical charge, shape, and atomic composition

 Receptor Down-regulation “A decrease in the total number of target-cell receptors for a given messenger/ligand in response to chronic high extracellular concentration of the messenger/ligand” Drug Receptors, contd.  Supersensitivity “The increased responsiveness of a target cell to a given messenger/ligand, resulting from receptor up-regulation”  Receptor Up-regulation “An increase in the total number of target-cell receptors for a given messenger/ligand in response to a chronic low extracellular concentration of the messenger/ligand”  Desensitization “The loss of a drug’s effect, when it is given continuously or repeatedly, on a short time-scale”  Often results from receptor down-regulation

Drug Receptor Interactions  Agonist “A chemical messenger (or drug) that binds to a receptor and triggers the cell’s response; often refers to a drug that mimics a normal messenger’s action”.  For example, pilocarpine is a muscarinic receptor agonist because it can bind to and activate muscarinic receptors  Antagonist "A molecule that competes for a receptor with a chemical messenger normally present in the body. The antagonist binds to the receptor but does not trigger the cell’s response”  For Example, atropine is a muscarinic receptor antagonist because it can bind to muscarinic receptors but it does not trigger the cell’s response. In this way, it prevents binding of acetylcholine (ACh) and similar agonist drugs to the ACh receptor

The Lock and Key Model of Signal- Receptor Interaction  Ligands such as hormones, neurotransmitters or drugs (the "key") affect target cells by binding to specific receptors (the "lock”), which are often located in the cell membrane  This binding "unlocks" the cell's response, so that the hormone or neurotransmitter can exert its effects Drug Receptor Interactions

AgonistReceptor Agonist-Receptor Interaction Lock and key mechanism

AntagonistReceptor Antagonist-Receptor Complex DENIED! Competitive Inhibition Drug Receptor Interactions

AgonistReceptor Antagonist ‘Inhibited’-Receptor DENIED! Non-competitive Inhibition Drug Receptor Interactions

Drug Receptor Interactions, contd.  Affinity The extent to which the ligand/drug is capable of binding and remained bound to receptor  High Affinity – the ligand binds well and remains bound long enough to activate the receptor  Low Affinity – the ligand binds less well and may not remain bound long enough to activate the receptor High Affinity

Low Affinity Drug Receptor Interactions, contd.  Affinity The extent to which the ligand/drug is capable of binding and remained bound to receptor.  High Affinity – the ligand binds well and remains bound long enough to activate the receptor  Low Affinity – the ligand binds less well and may not remain bound long enough to activate the receptor